R619-M63-303: CMV51p> SARS-CoV-2 S(1-1208)-2P-T4f-3C-His8-Strep2x2 Citations (1)

Originally described in: Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays.
Esposito D, Mehalko J, Drew M, Snead K, Wall V, Taylor T, Frank P, Denson JP, Hong M, Gulten G, Sadtler K, Messing S, Gillette W Protein Expr Purif. 2020 Jun 4;174:105686. doi: 10.1016/j.pep.2020.105686. PubMed Journal

---

Articles Citing R619-M63-303: CMV51p> SARS-CoV-2 S(1-1208)-2P-T4f-3C-His8-Strep2x2

Articles

SARS-CoV-2 Seroprevalence and Drug Use in Trauma Patients from Six Sites in the United States. Ngo TB, Karkanitsa M, Adusei KM, Graham LA, Ricotta EE, Darrah JR, Blomberg RD, Spathies J, Pauly KJ, Klumpp-Thomas C, Travers J, Mehalko J, Drew M, Hall MD, Memoli MJ, Esposito D, Kozar RA, Griggs C, Cunningham KW, Schulman CI, Crandall M, Neavyn M, Dorfman JD, Lai JT, Whitehill JM, Babu KM, Mohr NM, Van Heukelom J, Fell JC, Rooke W, Kalish H, Thomas FD, Sadtler K. medRxiv. 2021 Aug 11. doi: 10.1101/2021.08.10.21261849. PubMed

If you have published an article using this material, please email us at to have your article added to this page.